Center-Authored Papers

Filters: Keyword is Antigens, CD28  [Clear All Filters]
C
Capraru D, Müller A, Csernok E, Gross WL, Holl-Ulrich K, Northfield J, Klenerman P, Herlyn K, Holle J, Gottschlich S et al..  2008.  Expansion of circulating NKG2D+ effector memory T-cells and expression of NKG2D-ligand MIC in granulomaous lesions in Wegener's granulomatosis.. Clinical immunology (Orlando, Fla.). 127(2):144-50. Abstract
Chapuis AG, Casper C, Kuntz S, Zhu J, Tjernlund A, Diem K, Turtle CJ, Cigal ML, Velez R, Riddell SR et al..  2011.  HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo.. Blood. 117(20):5391-402. Abstract
G
Graves SS, Stone DM, Loretz C, Peterson LJ, Lesnikova M, Hwang B, Georges GE, Nash R, Storb R.  2011.  Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.. Transplantation. 91(8):833-40. Abstract
Graves SS, Stone D, Loretz C, Peterson L, McCune JS, Mielcarek M, Storb R.  2009.  Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig.. Transplantation. 88(3):317-22. Abstract
L
Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, Johnson D, Swetter S, Thompson J, Greenberg PD et al..  1999.  Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.. Nature medicine. 5(6):677-85. Abstract
Li Y, Bleakley M, Yee C.  2005.  IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response.. Journal of immunology (Baltimore, Md. : 1950). 175(4):2261-9. Abstract
Li Y, Yee C.  2008.  IL-21 mediated Foxp3 suppression leads to enhanced generation of antigen-specific CD8+ cytotoxic T lymphocytes.. Blood. 111(1):229-35. Abstract
Li L, Yee C, Beavo JA.  1999.  CD3- and CD28-dependent induction of PDE7 required for T cell activation.. Science (New York, N.Y.). 283(5403):848-51. Abstract
M
Muñoz NM, Trobridge GD, Kiem H-P.  2009.  Ex vivo expansion and lentiviral transduction of Macaca nemestrina CD4+ T cells.. Journal of medical primatology. 38(6):438-43. Abstract
P
Pufnock JS, Cigal M, Rolczynski LS, Andersen-Nissen E, Wolfl M, McElrath MJ, Greenberg PD.  2011.  Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28.. Blood. 117(24):6542-51. Abstract
S
Stromnes IM, Blattman JN, Tan X, Jeevanjee S, Gu H, Greenberg PD.  2010.  Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.. The Journal of clinical investigation. 120(10):3722-34. Abstract
T
Tanaka J, Mielcarek M, Torok-Storb B.  1998.  Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells.. Blood. 91(1):347-52. Abstract
Till BG, Jensen MC, Wang J, Qian X, Gopal AK, Maloney DG, Lindgren CG, Lin Y, Pagel JM, Budde LE et al..  2012.  CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.. Blood. 119(17):3940-50. Abstract
W
Wang J, Jensen M, Lin Y, Sui X, Chen E, Lindgren CG, Till B, Raubitschek A, Forman SJ, Qian X et al..  2007.  Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains.. Human gene therapy. 18(8):712-25. Abstract